Edgewise Therapeutics Inc. Common Stock vs Mitsubishi UFJ Financial Group Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while Mitsubishi UFJ Financial Group Inc. Common Stock trades at $21.65 (market cap $247.53B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 61.6× Edgewise Therapeutics Inc. Common Stock's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.46% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Mitsubishi UFJ Financial Group Inc. Common Stock for 2 Days on average.
| EWTX | MUFG | |
|---|---|---|
Market Cap | $4.02B | $247.53B |
Volume | 1,446,128 | 3,196,989 |
Sector | Health | Financials |
52-Week High | $48.35 | $24.13 |
52-Week Low | $14.89 | $14.77 |
Typical Hold Time | 0 Days | 2 Days |
Enterprise Value | $3.56B | $28.41T |
Dividend Yield | — | 2.46% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MUFG trades at $22.40, up 0.22% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.45 exceeding the $0.35 estimate. Fundamentals show robust profitability with a 34.22% net income margin and 12.6% ROE, while valuation ratios like a P/E of 14.99 appear reasonable. Recent news highlights a partnership with SkyDrive for eVTOL feasibility studies and positive analyst momentum coverage.
The outlook is supported by earnings momentum and a 100% buy rating from analysts, but risks include a high debt-to-asset ratio of 5.81 and significant negative cash flow trends. Investor sentiment is optimistic due to strong quarterly results and institutional interest, though technical weakness and macroeconomic sensitivity pose near-term challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →